Dashboard
Manage Tickers

ANVSAnnovis Bio, Inc.

NYSE annovisbio.com


$ 8.25 $ 0.23 (2.87 %)    

Thursday, 08-Aug-2024 15:57:11 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 449.44 $ 10.78 (2.46 %)
DIA $ 395.05 $ 7.28 (1.88 %)
SPY $ 531.56 $ 12.90 (2.49 %)
TLT $ 95.30 $ -0.61 (-0.64 %)
GLD $ 224.00 $ 3.45 (1.56 %)
$ 8.02
$ 7.92
$ 8.29 x 100
-- x --
$ 7.92 - $ 8.41
$ 4.53 - $ 22.49
224,768
na
86.81M
$ 1.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-02-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-03-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

annovis-announces-preclinical-data-demonstrating-synergistic-effect-of-buntanetap-combined-with-trulicity-in-a-mouse-model-of-alzheimers
Annovis Announces Preclinical Data Demonst...
08/06/2024 12:04:44

annovis-bio-secures-us-patent-for-treatment-of-acute-traumatic-brain-injury-with-buntanetap
Annovis Bio Secures U.S. Patent For Treatm...
07/24/2024 12:07:42

Annovis Bio Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneeri...

hc-wainwright--co-reiterates-buy-on-annovis-bio-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Anno...
07/17/2024 10:35:58

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $30 price tar...

annovis-bio-granted-fda-approval-to-transition-to-new-crystal-form-of-buntanetap
Annovis Bio Granted FDA Approval To Transi...
07/16/2024 12:00:56

costco-to-rally-more-than-10-here-are-10-top-analyst-forecasts-for-thursday
Costco To Rally More Than 10%? Here Are 10...
07/11/2024 12:47:29

hc-wainwright--co-maintains-buy-on-annovis-bio-raises-price-target-to-30
HC Wainwright & Co. Maintains Buy on Annov...
07/11/2024 11:45:36

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and raises the price target ...

why-seastar-medical-holding-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why SeaStar Medical Holding Shares Are Tra...
07/10/2024 17:18:59

annovis-bio-shares-resume-trade
Annovis Bio Shares Resume Trade
07/09/2024 13:39:59

annovis-shares-halted-on-circuit-breaker-to-downside
Annovis Shares Halted On Circuit Breaker T...
07/09/2024 13:35:44

why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session
Why NIO Shares Are Trading Lower By Over 8...
07/05/2024 16:59:40

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

peering-into-annovis-bios-recent-short-interest
Peering Into Annovis Bio's Recent Short In...
07/03/2024 19:00:19

whats-going-on-with-annovis-shares-today
What's Going On With Annovis Shares Today?
07/03/2024 11:12:32

Annovis Bio shares rise in premarket trading on positive Phase III Parkinson's study results for buntanetap, showing cognit...

tesla-paramount-global-annovis-bio-eli-lilly-amazon-why-these-5-stocks-are-on-investors-radars-today
Tesla, Paramount Global, Annovis Bio, Eli ...
07/03/2024 03:38:25

On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in p...

annovis-bio-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1015
Annovis Bio Shares Halted On Circuit Break...
07/02/2024 17:27:09

rodman--renshaw-reiterates-buy-on-annovis-bio-maintains-67-price-target
Rodman & Renshaw Reiterates Buy on Annovis...
07/02/2024 16:46:56

Rodman & Renshaw analyst Elemer Piros reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $67 price target.

whats-going-with-annovis-bio-shares-tuesday
What's Going With Annovis Bio Shares Tuesday?
07/02/2024 15:48:30

Annovis announced new data from its Phase III Parkinson's study. The study showed improvements on the Unified Parkinson'...

annovis-bio-announces-phase-iii-study-results-for-buntanetap-in-parkinsons-disease-demonstrates-dose-dependent-and-statistically-significant-cognitive-improvements-shows-significant-improvement-in-mds-updrs-scores-for-patients-with-over-3-year-diagnosis-and-those-with-postural-instability-and-gait-difficulties-achieves-statistically-significant-improvements-in-all-primary-and-secondary-endpoints
Annovis Bio Announces Phase III Study Resu...
07/02/2024 12:05:43

annovis-bio-files-provisional-patent-for-new-manufacturing-process-of-crystalline-form-of-buntanetap-which-has-demonstrated-exceptional-stability-and-efficacy
Annovis Bio Files Provisional Patent For N...
06/27/2024 12:06:25

This patent encompasses the methods for manufacturing the new crystalline form of buntanetap (CAS# 3032752-92-1), which has dem...

annovis-bio-files-new-patent-for-novel-solid-forms-of-buntanetap-with-us-patent-office-builds-on-provisional-patent-from-june-2023
Annovis Bio Files New Patent for Novel Sol...
06/26/2024 12:01:07

annovis-bio-selected-to-present-latest-alzheimers-study-data-at-alzheimers-association-international-conference-2024-in-philadelphia
Annovis Bio Selected to Present Latest Alz...
06/18/2024 12:14:59

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION